JAMA ONCOL 润色咨询

JAMA Oncology

出版年份：暂无数据 年文章数：1010 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2020-02-14 1e2321c7m65(暂无匿称)

    你会弄了吗156****8060暂无昵称 2020-01-16 00:00:00 发表:
    老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议

    156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2019-06-21 lovetcm

    22.416分，还怕什么sunliang 2019-04-17 发表::
    这个杂志分区是0区？    sunliang 2019-04-17 00:00:00 发表:
    这个杂志分区是0区？

    sunliang 2019-04-17 发表:: 这个杂志分区是0区？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2019-04-17 sunliang

    这个杂志分区是0区？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2018-06-28 lovetcm

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2017-07-16 gu_8183

    谁能预测明年会有多少分?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2017-06-15 ms8782559743879884

    新出的期刊，因子不低啊。jama的王牌号召力

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=584746, encodeId=65f1584e4659, content=你会弄了吗<span class="quote">156****8060暂无昵称 2020-01-16 00:00:00 发表:<br>老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议</span>, beContent=156****8060暂无昵称 2020-01-16 00:00:00 发表: 老师 你好 请问共同作者的版权转让协议怎么写 我注册了共同作者 但是没有找到版权转让协议, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0fb2030145, createdName=1e2321c7m65(暂无匿称), createdTime=Fri Feb 14 00:00:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572642, encodeId=48d65e2642d5, content=22.416分，还怕什么<span class="quote">sunliang 2019-04-17 发表::<br>这个杂志分区是0区？</span><span class="quote">sunliang 2019-04-17 00:00:00 发表:<br>这个杂志分区是0区？</span>, beContent=sunliang 2019-04-17 发表:: 这个杂志分区是0区？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri Jun 21 00:00:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569677, encodeId=4fe15696e774, content=这个杂志分区是0区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Wed Apr 17 00:00:00 CST 2019, time=2019-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558596, encodeId=9684558596fe, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：直接从15分到20分，太厉害了。按这个势头，明年25分是有望的。不过JCO，Lancet Onocolgy都涨得快。主要源于肿瘤本身研究的人多，被引次数占优, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=445, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Jun 28 21:26:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544539, encodeId=697e54453985, content=谁能预测明年会有多少分?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=gu_8183, createdTime=Sun Jul 16 19:15:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=836970, encodeId=97838369e057, content=新出的期刊，因子不低啊。jama的王牌号召力 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2635414011, createdName=ms8782559743879884, createdTime=Thu Jun 15 00:01:19 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533858, encodeId=f56d53385857, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：目前为止2.8+, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Wed Mar 08 16:17:00 CST 2017, time=2017-03-08, status=1, ipAttribution=)]
    2017-03-08 科研二狗

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：目前为止2.8+

    0

共37条页码: 2/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分